title: A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone.
abstract: Several components of the basement membrane zone (BMZ) have been identified as antigenic targets in autoimmune bullous diseases. We report a novel disease with autoantibodies to a BMZ antigen that is different from the targets described so far. The patient suffering from this disorder showed tense bullae and severe mucous membrane involvement rapidly responding to oral tetracyclines and colchicine. Histopathologic findings resembled those of dermatitis herpetiformis. Direct immunofluorescence microscopy showed linear deposits of IgG and C3 at the BMZ. By indirect immunofluorescence studies on split human skin, using both 1 M NaCl and suction blistering for dermal-epidermal separation, IgG antibodies localized exclusively to the dermal side of the split. The antibodies were mainly of the IgG4 sub-class. By Western blot analysis of epidermal and dermal extracts, the patient's serum unequivocally reacted with a dermal antigen of 200 kDa. It did not recognize bullous pemphigoid antigens (the autoantigen of epidermolysis bullosa acquisita), purified preparations of laminin-1 and laminin-5, or the recently described 105-kDa BMZ antigen. By immunoblotting of concentrated conditioned SCC-25 medium, the patient's antibodies reacted with a band of 200 kDa and several bands of lower molecular weight. No reactivity was seen with extracts of cultured human fibroblasts. By indirect immunogold electron microscopy, immunoreactants localized to the lower lamina lucida. After clearance of skin lesions, both indirect immunofluorescence and Western blot analysis became negative. This patient suffers from a novel autoimmune bullous disease with autoantibodies to a 200-kDa antigen of the BMZ.
authors.affiliation: Department of Dermatology, University of Würzburg, Germany.
authors.forename: D
authors.initials: D
authors.lastname: Zillikens
authors.forename: Y
authors.initials: Y
authors.lastname: Kawahara
authors.forename: A
authors.initials: A
authors.lastname: Ishiko
authors.forename: H
authors.initials: H
authors.lastname: Shimizu
authors.forename: J
authors.initials: J
authors.lastname: Mayer
authors.forename: C V
authors.initials: CV
authors.lastname: Rank
authors.forename: Z
authors.initials: Z
authors.lastname: Liu
authors.forename: G J
authors.initials: GJ
authors.lastname: Giudice
authors.forename: H H
authors.initials: HH
authors.lastname: Tran
authors.forename: M P
authors.initials: MP
authors.lastname: Marinkovich
authors.forename: E B
authors.initials: EB
authors.lastname: Bröcker
authors.forename: T
authors.initials: T
authors.lastname: Hashimoto
mesh_terms: D000818:Animals; D001323:Autoantibodies / Q000097:blood / Q000378:metabolism*; D001324:Autoantigens / Q000737:chemistry; D001327:Autoimmune Diseases / Q000276:immunology* / Q000473:pathology*; D001485:Basement Membrane / Q000737:chemistry / Q000276:immunology*; D003176:Complement C3 / Q000378:metabolism; D006801:Humans; D007074:Immunoglobulin G / Q000378:metabolism; D008297:Male; D051379:Mice; D016253:Microscopy, Immunoelectron; D008875:Middle Aged; D008970:Molecular Weight; D051381:Rats; D012872:Skin Diseases, Vesiculobullous / Q000276:immunology* / Q000473:pathology*
chemical_list: D001323:Autoantibodies; D001324:Autoantigens; D003176:Complement C3; D007074:Immunoglobulin G